Physician profile
Weiwei Xu
NPI 1992837702
$8,390.63
in general payments reported to CMS, 2019-2025
23 companies · $1,955 in 2025
The $1,955 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $651 · 2021: $70.63 · 2022: $3,224 · 2023: $1,228 · 2024: $1,052 · 2025: $1,955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,349 · Food and Beverage: $1,886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,349.42 |
| Food and Beverage | $1,885.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $4,198.94 | 2022-2025 | Urolift, Barrigel |
| Procept Biorobotics Corporation | $1,940.86 | 2024-2025 | Aquabeam System |
| Neotract INC. | $596.99 | 2020 | |
| Ferring Pharmaceuticals INC. | $312.22 | 2025 | Adstiladrin |
| Astellas Pharma US INC | $238.09 | 2019-2025 | Xtandi |
| Palette Life Sciences, INC. | $169.58 | 2023 | |
| Myriad Genetic Laboratories, INC. | $131.65 | 2022-2025 | Prolaris |
| Accord Healthcare, INC. | $118.97 | 2023-2025 | |
| Abbvie INC. | $111.37 | 2022-2025 | Botox |
| Abc Home Medical Supply, INC. | $74.72 | 2025 | |
| Janssen Biotech, INC. | $69.83 | 2019 | |
| Boston Scientific Corporation | $59.81 | 2019 | |
| Valencia Technologies Corporation | $57.18 | 2025 | Ecoin Device Kit |
| C. R. Bard, INC. & Subsidiaries | $52.10 | 2019-2025 | Bard Urinary Drainage Bag |
| Allergan, INC. | $48.99 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $45.90 | 2022 | |
| Antares Pharma, INC. | $44.67 | 2025 | Xyosted |
| Pfizer INC. | $25.92 | 2023 | |
| Olympus America INC. | $23.26 | 2023 | Itind System, Evis Exera III Video System Center, Soltive |
| Dendreon Pharmaceuticals LLC | $21.97 | 2019 | |
| Sumitomo Pharma America, INC. | $19.75 | 2025 | Gemtesa |
| 180 Medical, INC. | $16.26 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weiwei Xu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.